Oxford-based Perspectum grabs €34M to improve patient care for cancer and metabolic diseases
Oxford-based Perspectum, a medtech company, announced on Thursday, January 5, that it has secured $36M (approximately €34M) in the first close of a Series C round of funding led by Oppenheimer Holding.